T. Rowe Price Associates’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$250K Sell
11,453
-1,018
-8% -$22.2K ﹤0.01% 2609
2025
Q1
$231K Buy
12,471
+1,506
+14% +$27.9K ﹤0.01% 2571
2024
Q4
$293K Buy
10,965
+1,620
+17% +$43.3K ﹤0.01% 2512
2024
Q3
$220K Buy
+9,345
New +$220K ﹤0.01% 2619